<DOC>
	<DOC>NCT00944632</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of three concentrations of ZK 245186 ointment and vehicle on increasing body surface areas for the treatment of atopic dermatitis and to obtain dose-response information for the three concentrations.</brief_summary>
	<brief_title>Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>diagnosis of atopic dermatitis (Hanifin and Rajka criteria) mild to moderate atopic dermatitis at beginning of study washout periods for systemic and topical treatments for atopic dermatitis females must use effective contraception pregnant or lactating women conditions that in the opinion of the investigator may pose a risk or interfere with the evaluation of the study widespread atopic dermatitis requiring systemic treatment diagnosed with immunocompromised status skin diseases other than atopic dermatitis in the treatment area mental handicap or legally incompetent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>